Analysts Set Harrow, Inc. (NASDAQ:HROW) Price Target at $64.67

Key Points

• Harrow, Inc. (NASDAQ:HROW) has received a consensus rating of "Moderate Buy" from analysts, with one hold and seven buy ratings.
• The company's current stock price is $44.34, down 2.3% recently, with a 12-month range between $20.85 and $59.23.
• Institutional investors hold 72.76% of Harrow's stock, with significant recent increases in holdings from several large investment firms.

Harrow, Inc. (NASDAQ:HROW - Get Free Report) has earned an average recommendation of "Moderate Buy" from the eight brokerages that are currently covering the company, Marketbeat.com reports. One analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $64.50.

Several research analysts have recently weighed in on the stock. BTIG Research boosted their price target on shares of Harrow from $62.00 to $63.00 and gave the company a "buy" rating in a research report on Thursday, August 14th. Craig Hallum boosted their price objective on shares of Harrow from $54.00 to $64.00 and gave the company a "buy" rating in a report on Tuesday. Cantor Fitzgerald began coverage on shares of Harrow in a report on Friday, July 11th. They issued an "overweight" rating and a $76.00 price objective on the stock. HC Wainwright boosted their price target on shares of Harrow from $60.00 to $64.00 and gave the stock a "buy" rating in a research note on Wednesday, August 13th. Finally, Zacks Research lowered shares of Harrow from a "strong-buy" rating to a "hold" rating in a research note on Friday, September 12th.

Harrow Price Performance

Harrow stock traded up $2.71 during trading on Friday, reaching $48.80. The company had a trading volume of 434,647 shares, compared to its average volume of 492,235. Harrow has a 1-year low of $20.85 and a 1-year high of $59.23. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.58 and a current ratio of 0.62. The firm's 50-day simple moving average is $37.49 and its 200 day simple moving average is $30.80. The firm has a market capitalization of $1.81 billion, a PE ratio of -195.14 and a beta of 0.33.

Harrow (NASDAQ:HROW - Get Free Report) last announced its earnings results on Monday, August 11th. The company reported $0.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.23. The company had revenue of $63.74 million for the quarter, compared to analysts' expectations of $64.23 million. Harrow had a negative net margin of 4.49% and a negative return on equity of 2.18%. Harrow has set its FY 2025 guidance at EPS. As a group, equities research analysts anticipate that Harrow will post -0.53 earnings per share for the current fiscal year.

Institutional Trading of Harrow

A number of large investors have recently made changes to their positions in the company. GF Fund Management CO. LTD. acquired a new position in Harrow in the fourth quarter valued at approximately $25,000. Quarry LP purchased a new position in Harrow in the first quarter worth $32,000. Raymond James Financial Inc. purchased a new position in Harrow in the second quarter worth $48,000. State of Wyoming purchased a new position in Harrow in the first quarter worth $97,000. Finally, Tower Research Capital LLC TRC raised its position in Harrow by 345.0% in the second quarter. Tower Research Capital LLC TRC now owns 3,373 shares of the company's stock worth $103,000 after acquiring an additional 2,615 shares in the last quarter. 72.76% of the stock is currently owned by hedge funds and other institutional investors.

About Harrow

Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.